Ella T Rossa
Overview
Explore the profile of Ella T Rossa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
17
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Viguera A, Jones A, Szpunar M, Bernstein S, Killenberg P, Sojka E, et al.
J Womens Health (Larchmt)
. 2024 Jul;
33(12):1606-1613.
PMID: 39037008
Previous studies suggest an association between late pregnancy exposure to selective serotonin reuptake inhibitors (SSRIs) and serotonin norepinephrine reuptake inhibitors (SNRIs) and increased postpartum hemorrhage (PPH) risk. This is the...
2.
Vanderkruik R, Ferguson C, Kobylski L, Locascio J, Hamlett G, Killenberg P, et al.
JMIR Form Res
. 2024 Jan;
8:e44029.
PMID: 38277191
Background: Depression during pregnancy is increasingly recognized as a worldwide public health problem. If untreated, there can be detrimental outcomes for the mother and child. Anxiety is also often comorbid...
3.
Hock R, Feeney A, Harmon H, Caplin P, Kobylski L, Rossa E, et al.
Ann Clin Psychiatry
. 2023 Jul;
35(3):148-156.
PMID: 37459493
Background: Women with psychiatric disorders are vulnerable to relapse in pregnancy, and the COVID-19 pandemic has presented an additional stressor. Methods: Data came from a supplemental study offered to women...
4.
Szpunar M, Freeman M, Kobylski L, Rossa E, Gaccione P, Chitayat D, et al.
J Clin Psychopharmacol
. 2023 May;
43(4):326-332.
PMID: 37235505
Purpose/background: The prevalence of attention-deficit/hyperactivity disorder in adult females is 3% to 4%. Attention-deficit/hyperactivity disorder is highly comorbid with other psychiatric disorders such as mood, anxiety, and substance use disorders....
5.
Viguera A, Freeman M, Kobylski L, Rossa E, Gaccione P, Chitayat D, et al.
J Clin Psychopharmacol
. 2023 Feb;
43(2):106-112.
PMID: 36825887
Purpose/background: Since its US Food and Drug Administration approval in 1996, olanzapine has been one of the most commonly prescribed atypical antipsychotics, making a better understanding of its reproductive safety...
6.
Cohen L, Church T, Freeman M, Gaccione P, Caplin P, Kobylski L, et al.
J Womens Health (Larchmt)
. 2023 Jan;
32(4):452-462.
PMID: 36716275
Second-generation antipsychotics (SGAs), also called atypical antipsychotics, are common therapies for women with a spectrum of psychiatric disorders. No systematically ascertained human reproductive safety data are available for lurasidone, and...
7.
Viguera A, McElheny S, Caplin P, Kobylski L, Rossa E, Young A, et al.
J Clin Psychiatry
. 2023 Jan;
84(1).
PMID: 36602927
While poor neonatal adaptation syndrome (PNAS) has been particularly well described among infants exposed to antidepressants, specifically selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs), this is not...
8.
Lydecker J, Rossa E, Grilo C
Eat Weight Disord
. 2021 Apr;
27(2):515-524.
PMID: 33851327
Purpose: To examine how parents' and adolescents' weight histories were associated with parents' approach to eating/weight-related parenting and children's eating-disorder behaviors. Methods: Participants were 502 parents (69.3% mothers, 30.7% fathers)...